A Lecture: EGFR/HER2 Vaccine - Prof. Mark Mamula, Yale University School of Medicine

Updated: Dec 18, 2020

On Oct 3, 2020 CCRA hosted a scientific seminar by Professor Mark Mamula where he described his team's work on EGFR-peptide canine cancer vaccine. A summary of the work is described in a previous blog.

Here, we provide

  • the recording of the seminar,

  • the slides from the seminar, and

  • the story of Ranger - a golden retriever whose pulmonary metastasis disappeared after receiving vaccine injections.

According to Prof. Mamula, 5-6 dogs with osteosarcomain his study have experienced resolving of pulmonary metastasis.

Lecture and Q&A - Professor Mark Mamula

Lecture slides

Mamula Seminar
Download • 4.41MB

Ranger's story

Ranger is a golden retriever who was diagnosed with osteosarcoma in spring of 2019. After amputation surgery and chemotherapy treatment, he developed pulmonary metastasis by fall of 2019. His tumor disappeared after the vaccine treatment, as described by Ranger's dad, Rick Kneisel.

  • Facebook
  • Instagram end dog cancer

©2020 CCRA

CCRA is a 501(c)(3) non-profit organization. 

EIN 82-3762441